These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8584646)

  • 1. The colorful past and bright future of monoamine oxidase research.
    Singer TP
    Prog Brain Res; 1995; 106():1-22. PubMed ID: 8584646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fluorometric determination of monoaminoxidase activity with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as substrate].
    Ermakov NV; Ishkov AG; Mikerov SV; Miroshnichenko EV
    Vopr Med Khim; 1991; 37(3):67-8. PubMed ID: 1949694
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidation of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine, a 1-amino analog of MPTP, by type A and B monoamine oxidase.
    Umeda M; Aoyama S; Kaiya T; Kohda K; Maruyama W; Naoi M
    J Neural Transm (Vienna); 1998; 105(10-12):1253-64. PubMed ID: 9928894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical thoughts about the life of MAO.
    Silverman RB
    Prog Brain Res; 1995; 106():23-31. PubMed ID: 8584659
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sablin SO; Krueger MJ; Bachurin SO; Solyakov LS; Efange SM; Singer TP
    J Neurochem; 1994 May; 62(5):2012-6. PubMed ID: 8158148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic enzymes of neurotoxin: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Parkinson's disease].
    Wu RF; Ichikawa Y
    Seikagaku; 1995 Nov; 67(11):1307-11. PubMed ID: 8618071
    [No Abstract]   [Full Text] [Related]  

  • 7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
    J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
    Youngster SK; McKeown KA; Jin YZ; Ramsay RR; Heikkila RE; Singer TP
    J Neurochem; 1989 Dec; 53(6):1837-42. PubMed ID: 2809594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
    Vintém AP; Price NT; Silverman RB; Ramsay RR
    Bioorg Med Chem; 2005 May; 13(10):3487-95. PubMed ID: 15848762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.
    Kalgutkar AS; Castagnoli K; Hall A; Castagnoli N
    J Med Chem; 1994 Apr; 37(7):944-9. PubMed ID: 8151621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The structure-activity relationship in the dehydrogenation processes of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogs under the action of MAO].
    Sablin SO; Tkachenko SE; Bachurin SO
    Dokl Akad Nauk SSSR; 1991; 318(1):228-31. PubMed ID: 1893833
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetic characteristics of monoamine oxidase in brain regions of animals with varying degrees of sensitivity to 1-methyl, 4-phenyl, 1,2,3,6- tetrahydropyridine].
    Ishkov AG; Ermakov NV; Mikerov SV; Miroshnichenko EV
    Vopr Med Khim; 1991; 37(5):49-52. PubMed ID: 1759397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemical localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine oxidation in the mouse brain.
    Vincent SR
    Neuroscience; 1989; 28(1):189-99. PubMed ID: 2569695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference spectra for inhibitor binding to monoamine oxidases.
    Sablin SO; Ramsay RR
    Biochem Soc Trans; 1995 Aug; 23(3):457S. PubMed ID: 8566349
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mabic S; Castagnoli N
    J Med Chem; 1996 Sep; 39(19):3694-700. PubMed ID: 8809158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines.
    Yu J; Castagnoli N
    Bioorg Med Chem; 1999 Dec; 7(12):2835-42. PubMed ID: 10658587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of monoamine oxidases with tertiary amines.
    Singer TP; Ramsay RR
    Biochem Soc Trans; 1991 Feb; 19(1):211-5. PubMed ID: 2037153
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T; Arán VJ; Guillén H
    Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inactivation of monoamine oxidases A and B by tetrahydropyridines and dihydropyridines.
    Krueger MJ; McKeown K; Ramsay RR; Youngster SK; Singer TP
    Biochem J; 1990 May; 268(1):219-24. PubMed ID: 2344359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.